Compare MT & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MT | BDX |
|---|---|---|
| Founded | 1976 | 1897 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.8B | 43.0B |
| IPO Year | 2003 | 1998 |
| Metric | MT | BDX |
|---|---|---|
| Price | $73.62 | $189.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $66.60 | ★ $186.00 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | 1.06% | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $11.84 | N/A |
| Revenue Next Year | $4.96 | $3.02 |
| P/E Ratio | ★ $15.95 | $119.96 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $31.93 | $140.11 |
| 52 Week High | $75.66 | $213.08 |
| Indicator | MT | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 68.15 |
| Support Level | $64.27 | $141.69 |
| Resistance Level | $75.66 | $196.05 |
| Average True Range (ATR) | 1.67 | 4.24 |
| MACD | -0.36 | 0.35 |
| Stochastic Oscillator | 64.44 | 73.22 |
ArcelorMittal SA is an integrated steel and mining company. The company's reportable operating segments include North America, Brazil, Europe, India and JVs, Sustainable Solutions, and Mining. It generates maximum revenue from the Europe segment. The Europe segment produces hot-rolled coil, cold-rolled coil, coated products, tinplate, plate, and slab. These products are sold to customers in the automotive, general, and packaging sectors, as well as producing long products consisting of sections, wire rods, rebar, billets, blooms and wire drawing, and tubular products. Geographically, it derives a majority of its revenue from the United States, followed by Brazil, Canada, Mexico, Argentina, and other markets.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.